Terms: = Thyroid cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
29 results:
1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated thyroid cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
2. Markedly hypoechoic: a new definition improves the diagnostic performance of thyroid ultrasound.
Liu J; Luo T; Zhang H; Liu H; Gu Y; Chen X; Shi L; Guan L; Ni X; Zhang X; Zhang R; Jia X; Dong Y; Zhang J; Xu W; Zhou J
Eur Radiol; 2023 Nov; 33(11):7857-7865. PubMed ID: 37338557
[TBL] [Abstract] [Full Text] [Related]
3. cancer Risk Associated With
Cummings S; Alfonso A; Hughes E; Kucera M; Mabey B; Singh N; Eng C
JCO Precis Oncol; 2023 Jan; 7():e2200415. PubMed ID: 36634299
[TBL] [Abstract] [Full Text] [Related]
4. Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Kawaguchi H; Yamamoto Y; Saji S; Masuda N; Nakayama T; Aogi K; Anan K; Ohtani S; Sato N; Takano T; Tokunaga E; Nakamura S; Hasegawa Y; Hattori M; Fujisawa T; Morita S; Yamaguchi M; Yamashita T; Yotsumoto D; Toi M; Ohno S
Jpn J Clin Oncol; 2023 Mar; 53(3):203-211. PubMed ID: 36484305
[TBL] [Abstract] [Full Text] [Related]
5. Feline pulmonary carcinoma: Gross, histological, metastatic, and immunohistochemical aspects.
Santos IR; Raiter J; Lamego ÉC; Bandinelli MB; Dal Pont TP; Siqueira KF; Almeida BA; Panzeira W; Sonne L; Driemeier D; Pavarini SP
Vet Pathol; 2023 Jan; 60(1):8-20. PubMed ID: 36112908
[TBL] [Abstract] [Full Text] [Related]
6. Assessing the prognostic value of stemness-related genes in breast cancer patients.
Wang WJ; Wang H; Wang MS; Huang YQ; Ma YY; Qi J; Shi JP; Li W
Sci Rep; 2020 Oct; 10(1):18325. PubMed ID: 33110086
[TBL] [Abstract] [Full Text] [Related]
7. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary thyroid Carcinoma.
Mishra V; Kowtal P; Rane P; Sarin R
Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
[TBL] [Abstract] [Full Text] [Related]
8. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (cdkn2c) loss assay in sporadic medullary thyroid carcinoma.
Maxwell JE; Gule-Monroe MK; Subbiah V; Hu M; Perrier ND; Cabanillas ME; Lee JE; Graham PH; Cote GJ; Busaidy NL; Grubbs EG
Surgery; 2020 Jan; 167(1):80-86. PubMed ID: 31648931
[TBL] [Abstract] [Full Text] [Related]
9. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract] [Full Text] [Related]
10. Role of cdkn2c Fluorescence In Situ Hybridization in the Management of Medullary thyroid Carcinoma.
El Naofal M; Kim A; Yon HY; Baity M; Ming Z; Bui-Griffith J; Tang Z; Robinson M; Grubbs EG; Cote GJ; Hu P
Ann Clin Lab Sci; 2017 Sep; 47(5):523-528. PubMed ID: 29066476
[TBL] [Abstract] [Full Text] [Related]
11. Role of cdkn2c Copy Number in Sporadic Medullary thyroid Carcinoma.
Grubbs EG; Williams MD; Scheet P; Vattathil S; Perrier ND; Lee JE; Gagel RF; Hai T; Feng L; Cabanillas ME; Cote GJ
Thyroid; 2016 Nov; 26(11):1553-1562. PubMed ID: 27610696
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence.
Park YM; Wang SG; Lee JC; Shin DH; Kim IJ; Son SM; Mun M; Lee BJ
Head Neck; 2016 Apr; 38 Suppl 1():E1172-6. PubMed ID: 26268535
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
Kunstman JW; Juhlin CC; Goh G; Brown TC; Stenman A; Healy JM; Rubinstein JC; Choi M; Kiss N; Nelson-Williams C; Mane S; Rimm DL; Prasad ML; Höög A; Zedenius J; Larsson C; Korah R; Lifton RP; Carling T
Hum Mol Genet; 2015 Apr; 24(8):2318-29. PubMed ID: 25576899
[TBL] [Abstract] [Full Text] [Related]
14. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.
Barbieri RB; Bufalo NE; Secolin R; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
Eur J Endocrinol; 2014 Dec; 171(6):761-7. PubMed ID: 25565272
[TBL] [Abstract] [Full Text] [Related]
15. Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.
Demeure MJ; Aziz M; Rosenberg R; Gurley SD; Bussey KJ; Carpten JD
World J Surg; 2014 Jun; 38(6):1296-305. PubMed ID: 24633422
[TBL] [Abstract] [Full Text] [Related]
16. Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.
Pita JM; Figueiredo IF; Moura MM; Leite V; Cavaco BM
J Clin Endocrinol Metab; 2014 Mar; 99(3):E497-507. PubMed ID: 24423316
[TBL] [Abstract] [Full Text] [Related]
17. Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
Erdas E; Aste N; Pilloni L; Nicolosi A; Licheri S; Cappai A; Mastinu M; Cetani F; Pardi E; Mariotti S; Pomata M
BMC Cancer; 2012 Dec; 12():614. PubMed ID: 23259638
[TBL] [Abstract] [Full Text] [Related]
18. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.
Neta G; Brenner AV; Sturgis EM; Pfeiffer RM; Hutchinson AA; Aschebrook-Kilfoy B; Yeager M; Xu L; Wheeler W; Abend M; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ
Carcinogenesis; 2011 Aug; 32(8):1231-7. PubMed ID: 21642358
[TBL] [Abstract] [Full Text] [Related]
19. Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.
Nascimento C; Borget I; Al Ghuzlan A; Deandreis D; Chami L; Travagli JP; Hartl D; Lumbroso J; Chougnet C; Lacroix L; Baudin E; Schlumberger M; Leboulleux S
Endocr Relat Cancer; 2011 Apr; 18(2):R29-40. PubMed ID: 21183629
[TBL] [Abstract] [Full Text] [Related]
20. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
[TBL] [Abstract] [Full Text] [Related]
[Next]
